BioSpace23h
FDA Misses Review Deadline for Novavax’s COVID-19 Shot, Days After Marks’ Resignation
The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1.
BioSpace21h
Sarepta’s Duchenne Gene Therapy Placed on Hold in Europe Pending Death Investigation
The European Medicines Agency asked for three clinical trials to be placed on hold until the exact cause of death of a US ...
BioSpace23h
Secretive Biotech Xaira Hires Top AI Academic To Take His Work to ‘the Next Level’
Bo Wang is a renowned AI scientist at the University of Toronto. He’s bringing his open-source culture and computational ...
BioSpace17h
FDA Layoffs Continue as Former Commissioner Robert Califf Speaks Out
The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were ...
BioSpace23h
BeiGene Scraps TIGIT Candidate After Underwhelming Lung Cancer Data
An independent data monitoring board found that BeiGene’s ociperlimab was unlikely to significantly boost overall survival in patients with untreated NSCLC.
BioSpace1d
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector ...